Abstract

Untreated anemia can caused significant cardiac and kidney damage. The aim of this study was to investigate the efficiency of anemia and hyperglycemia treatment in type 2 diabetes and their impact on kidney and heart impairment. The study is clinical retrospective and prospective and it was conducted in Clinic of Endocrinology, Diabetes Mellitus and Metabolic Diseases, University Clinical Center of Sarajevo. Prior to the study all patients were taking oral hypoglycemic drugs included sulfonylureas and biguanides. These subjects were put on 2 times daily fix mix insulin and biguanides after lunch. Each day, subjects received Iron tab 1 x 100 mg/ day, and C vitamin 1 x 100 mg/day. The results of our study are showing that effective treatment of glycaemia and anemia in patients with diabetes, reduces blood pressure, urine albumin secretion and pulse rate, diminishing cardiovascular damage and improving kidney function.

Highlights

  • People with diabetes have suffered from anemia for a number of years before receiving treatment

  • Patients with chronic kidney disease and anemia experience an increased risk of stroke compared to patients without chronic kidney disease

  • Anemia therapy in patients with heart failure may reduce the risk of subsequent hospitalization, and anemia therapy in patients with chronic kidney disease not on dialysis may reduce the risk of progression of chronic kidney disease (, )

Read more

Summary

Introduction

People with diabetes have suffered from anemia for a number of years before receiving treatment. Heart has to work harder to pump blood around the body due to the limited amount of oxygen – carrying hemoglobin through the blood stream, what can deteriorate a high risk of coronary heart disease in people with type diabetes ( , , , ). Patients with chronic kidney disease and anemia experience an increased risk of stroke compared to patients without chronic kidney disease. Anemia therapy in patients with heart failure may reduce the risk of subsequent hospitalization, and anemia therapy in patients with chronic kidney disease not on dialysis may reduce the risk of progression of chronic kidney disease ( , ).

Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.